|
Match
|
Document |
Document Title |
|
|
8182831 |
Stable and taste masked pharmaceutical dosage form using porous apatite grains
A stable and taste masked pharmaceutical dosage form includes porous apatite grains and a drug entrapped in pores of said grains, wherein said grains have a size of 0.1-1000 μm and said pores of ...
|
|
|
8153612 |
Injectable chitosan mixtures forming hydrogels
A chitosan composition which forms a hydrogel at near physiological pH and 37° C., comprising at least one type of chitosan having a degree of acetylation in the range of from about 30% to about ...
|
|
|
8153591 |
Protein biomaterials and biocoacervates and methods of making and using thereof
The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates...
|
|
|
8137696 |
Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
The present invention relates to a three dimensional, malleable cell culture composition and method of forming the same comprising hyaluronic acid, chitosan and a polyelectrolytic complex of...
|
|
|
8133869 |
Compositions containing poly[beta(1,4)-2-amino-2-deoxyglucopyranose] oligomers in a solution of modified lignin phenols and their uses
The present invention refers to biocidal mixtures with disinfecting and microbicidal activity which also enhance root growth, containing as active ingredients...
|
|
|
8106030 |
Hemostatic material
A hemostatic powder comprises a chitosan salt together with at least one inert material. The disclosure also relates to hemostatic powders into which fluid penetrability is 0.5 cm or more within 1...
|
|
|
8039449 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Hemostatic material
A hemostatic powder comprises a chitosan salt together with at least one inert material. The disclosure also relates to hemostatic powders into which fluid penetrability is 0.5 cm or more within 1...
|
|
|
8039448 |
N-acylated chitinous polymers and methods of use thereof
The invention pertains to N-acetylated, N, O-carboxyalkylchitosans and methods for using the chitosans to treat disorders, such as cancer, nervous system disorders, urinary tract disorders, and...
|
|
|
8017595 |
Methods of drug delivery using sulphated chitinous polymers
The present invention provides methods and compositions for delivering a therapeutic agent across a membrane that has limited permeability for the therapeutic agent. The method includes delivering...
|
|
|
7985742 |
Synergistic compositions of polysaccharides as natural and biodegradable absorbent materials or super absorbents
A multi-component synergistic absorbent composition includes at least one polysaccharide and at least one or more polysaccharide-based components or gelling proteins. This composition possesses...
|
|
|
7985741 |
Pharmaceutical composition comprising chito-oligomers
Compositions are provided comprising chito-oligomers obtainable from chitin, comprising oligomers of N-acetyl glucosamine (NAG) and glucosamine, wherein at least 50% of the oligomers have a chain...
|
|
|
7981872 |
Hemostatic material
A hemostatic powder comprises a chitosan salt together with at least one medical surfactant. At least one inert material may optionally be included. The hemostatic powder may be incorporated into...
|
|
|
7964582 |
Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers
The present invention features a method of treating atrophy of skin or mucosal tissue by administering to skin or mucosal tissue in need of such treatment a composition including a tensioning...
|
|
|
7943597 |
Phosphate-binding chitosan and uses thereof
The present invention provides compositions and methods for removing phosphate from a subject using chitosan. The present invention also provides compositions and methods for treating...
|
|
|
7901707 |
Biodegradable biocompatible implant and method of manufacturing same
Formulations or delivery systems are provided for controlled release of therapeutically active agents. The delivery systems are composed of polymer and lipid materials and may be prepared as a gel,...
|
|
|
7897585 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one anti-hemophilic factor or bioactive agent characterized with a positive surface charge and their...
|
|
|
7884088 |
Functionalized organic oligomers using homogeneous modification method for molecular binding
A method of homogeneously forming functionalized biocompatible oligomers includes the steps of dissolving a biocompatible oligomer in a solvent to form a solution, and admixing at least one π ...
|
|
|
7879819 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics or equivalent bioactive agent characterized with a positive surface charge and their...
|
|
|
7871988 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced...
|
|
|
7871989 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid as drug carriers, and encapsulating at least one bioactive agent. The nanoparticles are characterized with a...
|
|
|
7871990 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced...
|
|
|
7867984 |
Nanoparticles for protein drug delivery
The invention discloses the bioactive nanoparticles composed of chitosan, poly-glutamic acid, and at least one appetite-suppressing agent characterized with a positive surface charge and a method...
|
|
|
7863258 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antineoplastic drug or cancer therapeutic agent characterized with a positive surface charge and...
|
|
|
7863259 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics or equivalent bioactive agent characterized with a positive surface charge and their...
|
|
|
7863257 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced...
|
|
|
7858596 |
Nanoparticles for protein drug delivery
The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced...
|
|
|
7854923 |
Biopolymer system for tissue sealing
A tissue sealant for use in surgical and medical procedures for sealing the tissues of a living mammal is provided. The tissue sealant comprises a hydrogel which is formed by gelation of a premix...
|
|
|
7851458 |
Cartilage enhancing food supplements and methods of preparing the same
A food supplement, either in the form of a snack bar or a beverage, which contains one or more cartilage enhancing supplements is provided. The cartilage supplements include chondroitin,...
|
|
|
7820872 |
Wound dressings, apparatus, and methods for controlling severe, life-threatening bleeding
A chitosan biomaterial is frozen in aqueous solution to form a frozen chitosan structure from which water is removed by a prescribed freeze-drying process to form a sponge-like chitosan structure...
|
|
|
7807650 |
Methods and compositions for the treatment of intestinal conditions
Methods and compositions for the treatment of intestinal disorders, such as IBD and Crohn's disease, are disclosed. Preferred compositions include siNA. Also disclosed is a method of specifically...
|
|
|
7799766 |
Composition for treating hormonally-dependent cancers
Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory...
|
|
|
7776840 |
Methods of use of biomaterial and injectable implant containing biomaterial
This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative...
|
|
|
7767456 |
Non-viral gene delivery system
The present invention concerns a composition comprising complexes of cationic chitosan oligomers derived from the cationic polysaccharide chitosan, wherein said cationic oligomers contain a weight...
|
|
|
7736423 |
Aqueous composition for outdoor paints, indoor paints, facade paints and roof paints
The present invention relates to an aqueous composition for outdoor, indoor, facade and roof paints having a biocidal action.
|
|
|
7700574 |
Modulation of RANKL expression
Compounds, compositions and methods are provided for modulating the expression of RANKL. The compositions comprise oligonucleotides, targeted to nucleic acid encoding RANKL. Methods of using these...
|
|
|
7700131 |
Powders having contact biocidal properties
Powders having contact biocidal properties comprise a polysaccharide carrying atomic/metallic silver. The preferred polysaccharide is chitin, although other polysaccharides including chitosan,...
|
|
|
7700578 |
Capsule composition for use as immunogen against Campylobacter jejuni
An immunogenic composition, and method of using the composition to elicit an immune response to Campylobacter jejuni. The composition is an isolated polysaccharide polymer composed of one or more...
|
|
|
7696179 |
Inhibition of gene expression using RNA interfering agents
The present invention is based, at least in part, on the discovery of compositions and methods for the treatment and prevention of infectious diseases or disorders, e.g., HIV infection, AIDS, and...
|
|
|
7691830 |
Method and composition for treatment of a mucosal tissue disorder
Methods of treating a subject suffering from a disorder in a mucosal tissue, such as interstitial cystitis; cancer in a mucous membrane such as bladder or vaginal cancer; Crohn's disease;...
|
|
|
7683039 |
Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
The present invention is directed to a water soluble, randomly substituted partial N-, partial O-acetylated chitosans or chitosan derivatives and methods of preparing water soluble, randomly...
|
|
|
7682702 |
Process for preparing water-absorbing polymer particles
A process for producing water-absorbing polymeric particles comprises the steps of i) drying a hydrogel to produce a dried hydrogel,ii) separating incompletely dried polymeric particles from the...
|
|
|
7648969 |
Low molecular weight chitosan oligosaccharides and its preparation method
The present invention relates to low molecular weight chitosan oligosaccharides and its preparation method. Chitosan oligosaccharides were obtained under microwave irradiation assisted the...
|
|
|
7612029 |
Controlled release using gels in a melamine foam
A substrate comprising a nonwoven layer containing an ionically crosslinked polymer can be used to control the release of active ingredients. The substrate can be a melamine foam and contain a...
|
|
|
7605146 |
Process for producing an amide compound
There is disclosed a process for producing an amide compound, which process is characterized in that a compound having an amino group are reacted with a polyaminopolycarboxylic acid anhydride in...
|
|
|
7595061 |
Method for using an induced formation of chitinase in lawn and garden soil for the control of destructive insects and microorganisms therein
A method for controlling the growth of destructive insects and microorganisms in ground soil, includes the step of adding chitin to ground soil for inducing bacteria in the ground soil to...
|
|
|
7595307 |
Polysaccharide derivatives and uses in induction of an immune response
The present invention generally provides compositions comprising a polysaccharide derivative, and methods of their preparation and use for the prevention or treatment of diseases caused by...
|
|
|
7557094 |
Skin cream composition
The present invention is related to compositions containing chitosan conjugated CLA (conjugated linoleic acid) and a chitosan conjugated Vitamin A or a β-cyclodextrin conjugated vitamin A. The ...
|
|
|
7524514 |
Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
The present invention relates to a three dimensional, malleable cell culture composition and method of forming the same comprising hyaluronic acid, chitosan and a polyelectrolytic complex of...
|
|
|
7514469 |
Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-ring flavonoids and flavans—for use in the prevention and tre...
|
|
|
7514399 |
Bonding tissues and cross-linking proteins with naphthalimide compounds
Naphthalimide compounds are used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide...
|